Literature DB >> 1723386

Follitropin receptor down-regulation involves a cAMP-dependent post-transcriptional decrease of receptor mRNA expression.

A P Themmen1, L J Blok, M Post, W M Baarends, J W Hoogerbrugge, M Parmentier, G Vassart, J A Grootegoed.   

Abstract

The regulation by FSH (follitropin; follicle-stimulating hormone) of FSH receptor mRNA and protein (FSH binding) was studied using cultured Sertoli cells isolated from 21-day-old rats. FSH induced a dose-dependent and almost complete down-regulation of receptor mRNA at 4 h after addition of the hormone. At subsequent time points (16 h and later) the FSH receptor mRNA levels had returned close to control values. The effect of FSH was mimicked by dibutyryl cyclic AMP (dbcAMP) and forskolin, and the phosphodiesterase inhibitor methyl-isobutylxanthine (MIX) prolonged the FSH action. These findings indicate that the effect of FSH on its receptor mRNA was mediated by cAMP. A down-regulatory effect of FSH and dbcAMP on FSH receptor mRNA was also observed in the presence of the protein synthesis inhibitor cycloheximide, suggesting a direct effect of FSH/dbcAMP on the expression of the FSH receptor gene. Transcriptional run-on experiments revealed that FSH did not inhibit initiation of the FSH receptor gene; hence a post-transcriptional mechanism is involved. Binding of 125I-FSH to the cultured Sertoli cells was rapidly (4 h) decreased when the cells were incubated with FSH or FSH in combination with MIX. This effect can be explained by ligand-induced receptor sequestration. In contrast, incubation of Sertoli cells with dbcAMP had no effect on binding of 125I-FSH after 4 h, but resulted in a 60% loss of FSH binding sites after 24 h, probably caused by decreased mRNA expression. In conclusion, FSH receptor down-regulation in Sertoli cells is effected not only by the well-documented ligand-induced loss of receptors from the plasma membrane, but also involves a cAMP-mediated decrease of FSH receptor mRNA through a post-transcriptional mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723386     DOI: 10.1016/0303-7207(91)90130-k

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  16 in total

1.  Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal E box element.

Authors:  L L Heckert
Journal:  Mol Endocrinol       Date:  2001-05

Review 2.  Structure, function and regulation of gonadotropin receptors - a perspective.

Authors:  K M J Menon; Bindu Menon
Journal:  Mol Cell Endocrinol       Date:  2012-02-09       Impact factor: 4.102

Review 3.  Current concepts of follicle-stimulating hormone receptor gene regulation.

Authors:  Jitu W George; Elizabeth A Dille; Leslie L Heckert
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

Review 4.  The expression of the follicle-stimulating hormone receptor in spermatogenesis.

Authors:  Leslie L Heckert; Michael D Griswold
Journal:  Recent Prog Horm Res       Date:  2002

5.  Impaired fertility and FSH synthesis in gonadotrope-specific Foxl2 knockout mice.

Authors:  Stella Tran; Xiang Zhou; Christine Lafleur; Michael J Calderon; Buffy S Ellsworth; Sarah Kimmins; Ulrich Boehm; Mathias Treier; Derek Boerboom; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2013-01-22

6.  Molecular cloning and functional analysis of the FSH receptor gene promoter from the volcano mouse (Neotomodon alstoni alstoni).

Authors:  Marco Allán Pérez-Solis; Héctor Macías; Adriana Acosta-MontesdeOca; Ana María Pasapera; Reyna Fierro; Alfredo Ulloa-Aguirre; Rubén Gutiérrez-Sagal
Journal:  Endocrine       Date:  2009-10-28       Impact factor: 3.633

7.  Follicle-stimulating hormone (FSH) transiently blocks FSH receptor transcription by increasing inhibitor of deoxyribonucleic acid binding/differentiation-2 and decreasing upstream stimulatory factor expression in rat Sertoli cells.

Authors:  Pushpa Viswanathan; Michelle A Wood; William H Walker
Journal:  Endocrinology       Date:  2009-05-07       Impact factor: 4.736

8.  Recombinant gonadotropin therapy to improve spermatogenesis in nonobstructive azoospermic patients - A proof of concept study.

Authors:  Rita Jakubcionyte Laursen; Birgit Alsbjerg; Helle Olesen Elbaek; Betina Boel Povlsen; Kirsten Brock Spanggaard Jensen; Jette Lykkegaard; Sandro C Esteves; Peter Humaidan
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

9.  Effects of FSH on testicular mRNA transcript levels in the hypogonadal mouse.

Authors:  M H Abel; D Baban; S Lee; H M Charlton; P J O'Shaughnessy
Journal:  J Mol Endocrinol       Date:  2009-01-09       Impact factor: 5.098

10.  Rat testicular germ cells and Sertoli cells release different types of bioactive transforming growth factor beta in vitro.

Authors:  Bart L Haagmans; Jos W Hoogerbrugge; Axel P N Themmen; Katja J Teerds
Journal:  Reprod Biol Endocrinol       Date:  2003-02-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.